Loading clinical trials...
Loading clinical trials...
T cell acute lymphoblastic leukemia (T-ALL)/Lymphoblastic lymphoma (LBL) is a hematological malignancy caused by malignant transformation and clonal expansion of T-lineage precursor cells. The long-te...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
First Affiliated Hospital of Zhejiang University
NCT06855810 · Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, and more
NCT07577531 · T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
The First Affiliated Hospital, College of Medicine, Zhejiang University
Hangzhou
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions